EVOLENT HEALTH INC's ticker is EVH and the CUSIP is 30050B101. A total of 190 filers reported holding EVOLENT HEALTH INC in Q4 2018. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $115,433,361 | +0.5% | 4,239,198 | +11.9% | 0.02% | +4.5% |
Q2 2023 | $114,822,880 | +41.6% | 3,789,534 | +51.6% | 0.02% | +37.5% |
Q1 2023 | $81,106,666 | +120.5% | 2,499,435 | +90.8% | 0.02% | +128.6% |
Q4 2022 | $36,780,336 | +45.4% | 1,309,841 | +86.0% | 0.01% | +40.0% |
Q3 2022 | $25,296,000 | +26.2% | 704,031 | +7.9% | 0.01% | +25.0% |
Q2 2022 | $20,039,000 | +150.9% | 652,518 | -55.6% | 0.00% | +100.0% |
Q1 2020 | $7,988,000 | -75.8% | 1,470,988 | -59.6% | 0.00% | -71.4% |
Q4 2019 | $32,949,000 | +177.2% | 3,640,800 | +120.3% | 0.01% | +133.3% |
Q3 2019 | $11,885,000 | +3479.8% | 1,652,988 | +3856.1% | 0.00% | – |
Q2 2019 | $332,000 | -37.7% | 41,783 | -1.3% | 0.00% | – |
Q1 2019 | $533,000 | -56.0% | 42,352 | -30.2% | 0.00% | – |
Q4 2018 | $1,210,000 | -32.0% | 60,664 | -3.2% | 0.00% | – |
Q3 2018 | $1,780,000 | +62.4% | 62,676 | +20.3% | 0.00% | – |
Q2 2018 | $1,096,000 | +51.0% | 52,098 | +2.2% | 0.00% | – |
Q1 2018 | $726,000 | +25.8% | 50,974 | +8.6% | 0.00% | – |
Q4 2017 | $577,000 | +10.3% | 46,936 | +60.0% | 0.00% | – |
Q3 2017 | $523,000 | – | 29,331 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Voce Capital Management LLC | 323,694 | $9,807,928 | 16.97% |
Engaged Capital LLC | 1,747,252 | $52,941,736 | 7.66% |
Greenhouse Funds LLLP | 1,399,260 | $42,397,578 | 3.31% |
Rock Point Advisors, LLC | 330,448 | $10,012,574 | 3.29% |
FORMULA GROWTH LTD | 299,510 | $9,075,153 | 2.89% |
Rock Springs Capital Management LP | 3,803,500 | $115,246,050 | 2.74% |
Granahan Investment Management | 2,914,350 | $88,304,805 | 2.72% |
SECTORAL ASSET MANAGEMENT INC | 488,142 | $14,790,703 | 2.47% |
Summit Creek Advisors LLC | 557,070 | $16,879,221 | 2.11% |
Orbimed Advisors | 2,895,632 | $87,737,650 | 1.59% |